Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 4 | 4 | PSYCHIATRY//PSYCHOLOGY, CLINICAL//PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | 1867560 |
| 61 | 3 | SUBSTANCE ABUSE//CANNABINOID//CANNABIS | 92118 |
| 471 | 2 | CANNABINOID//ENDOCANNABINOIDS//ANANDAMIDE | 16110 |
| 29842 | 1 | ANANDAMIDE TRANSPORT INHIBITORS//ANTIGLAUCOMA ACTIVITY//ANTIGLAUCOMATOUS DRUGS | 195 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | ANANDAMIDE TRANSPORT INHIBITORS | authKW | 161625 | 1% | 100% | 1 |
| 2 | ANTIGLAUCOMA ACTIVITY | authKW | 161625 | 1% | 100% | 1 |
| 3 | ANTIGLAUCOMATOUS DRUGS | authKW | 161625 | 1% | 100% | 1 |
| 4 | C MONDIO FDN | address | 161625 | 1% | 100% | 1 |
| 5 | CANASOL | authKW | 161625 | 1% | 100% | 1 |
| 6 | CANNABINOID RETINA | authKW | 161625 | 1% | 100% | 1 |
| 7 | CB1 CB2 RECEPTOR AGONIST | authKW | 161625 | 1% | 100% | 1 |
| 8 | CB2RS | authKW | 161625 | 1% | 100% | 1 |
| 9 | CID16020046 | authKW | 161625 | 1% | 100% | 1 |
| 10 | CORNEAL MIGRATION | authKW | 161625 | 1% | 100% | 1 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Ophthalmology | 7042 | 51% | 0% | 99 |
| 2 | Pharmacology & Pharmacy | 450 | 29% | 0% | 57 |
| 3 | Neurosciences | 353 | 26% | 0% | 51 |
| 4 | Substance Abuse | 30 | 2% | 0% | 4 |
| 5 | Chemistry, Medicinal | 25 | 4% | 0% | 8 |
| 6 | Integrative & Complementary Medicine | 10 | 1% | 0% | 2 |
| 7 | Zoology | 8 | 3% | 0% | 6 |
| 8 | Anatomy & Morphology | 7 | 1% | 0% | 2 |
| 9 | Physiology | 7 | 3% | 0% | 6 |
| 10 | Toxicology | 3 | 2% | 0% | 4 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | C MONDIO FDN | 161625 | 1% | 100% | 1 |
| 2 | FTMS | 161625 | 1% | 100% | 1 |
| 3 | GLAUCOMA PHARMACOL | 161625 | 1% | 100% | 1 |
| 4 | INTERACT GENES RISQUES ENVIRONM EFFETS SANTE EA | 161625 | 1% | 100% | 1 |
| 5 | INVEST CLIN CIC | 161625 | 1% | 100% | 1 |
| 6 | MONDINO TOR VERGATA EXPT NEUROPHARMA AB N | 161625 | 1% | 100% | 1 |
| 7 | NEUROPHARMCOL | 161625 | 1% | 100% | 1 |
| 8 | OPHTHALMOL ASL 8 | 161625 | 1% | 100% | 1 |
| 9 | PHARM SCI DRUG | 161625 | 1% | 100% | 1 |
| 10 | PHARMACOL PRECLIN TOXICOL NAT PROD | 161625 | 1% | 100% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | CURRENT EYE RESEARCH | 9075 | 9% | 0% | 17 |
| 2 | NEURAL PLASTICITY | 6511 | 3% | 1% | 6 |
| 3 | VISUAL NEUROSCIENCE | 6018 | 5% | 0% | 9 |
| 4 | JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS | 4675 | 4% | 0% | 7 |
| 5 | JOURNAL OF TOXICOLOGY-CUTANEOUS AND OCULAR TOXICOLOGY | 3063 | 2% | 1% | 3 |
| 6 | EXPERIMENTAL EYE RESEARCH | 2920 | 6% | 0% | 11 |
| 7 | INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2659 | 9% | 0% | 18 |
| 8 | MOLECULAR VISION | 1735 | 3% | 0% | 6 |
| 9 | OPHTHALMIC RESEARCH | 1202 | 2% | 0% | 4 |
| 10 | PROGRESS IN NEURO-PSYCHOPHARMACOLOGY | 1161 | 1% | 1% | 1 |
Author Key Words |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | ANANDAMIDE TRANSPORT INHIBITORS | 161625 | 1% | 100% | 1 | Search ANANDAMIDE+TRANSPORT+INHIBITORS | Search ANANDAMIDE+TRANSPORT+INHIBITORS |
| 2 | ANTIGLAUCOMA ACTIVITY | 161625 | 1% | 100% | 1 | Search ANTIGLAUCOMA+ACTIVITY | Search ANTIGLAUCOMA+ACTIVITY |
| 3 | ANTIGLAUCOMATOUS DRUGS | 161625 | 1% | 100% | 1 | Search ANTIGLAUCOMATOUS+DRUGS | Search ANTIGLAUCOMATOUS+DRUGS |
| 4 | CANASOL | 161625 | 1% | 100% | 1 | Search CANASOL | Search CANASOL |
| 5 | CANNABINOID RETINA | 161625 | 1% | 100% | 1 | Search CANNABINOID+RETINA | Search CANNABINOID+RETINA |
| 6 | CB1 CB2 RECEPTOR AGONIST | 161625 | 1% | 100% | 1 | Search CB1+CB2+RECEPTOR+AGONIST | Search CB1+CB2+RECEPTOR+AGONIST |
| 7 | CB2RS | 161625 | 1% | 100% | 1 | Search CB2RS | Search CB2RS |
| 8 | CID16020046 | 161625 | 1% | 100% | 1 | Search CID16020046 | Search CID16020046 |
| 9 | CORNEAL MIGRATION | 161625 | 1% | 100% | 1 | Search CORNEAL+MIGRATION | Search CORNEAL+MIGRATION |
| 10 | DRIVING IMPAIRMENTS | 161625 | 1% | 100% | 1 | Search DRIVING+IMPAIRMENTS | Search DRIVING+IMPAIRMENTS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |